FREE NEWSLETTER: Econintersect sends a nightly newsletter highlighting news events of the day, and providing a summary of new articles posted on the website. Econintersect will not sell or pass your email address to others per our privacy policy. You can cancel this subscription at any time by selecting the unsubscribing link in the footer of each email.

Insider buying dropped a little last week with insiders buying $32.38 million of stock compared to $33.73 million in the week prior. Selling increased with insiders selling $897.75 million of stock last week compared to $812.44 million in the week prior.

Sell/Buy Ratio: The insider Sell/Buy ratio is calculated by dividing the total insider sales in a given week by total insider purchases that week. The adjusted ratio for last week went up to 27.74. In other words, insiders sold almost 28 times as much stock as they purchased. The Sell/Buy ratio this week compares unfavorably with the prior week, when the ratio stood at 24.1.

Follow up:

We are calculating an adjusted ratio by removing transactions by funds and companies and trying as best as possible only to retain information about insiders and 10% owners who are not funds or companies.

Insider Sell Buy Ratio August 22, 2014

Note: As mentioned in the first post in this series, certain industries have their preferred metrics such as same store sales for retailers, funds from operations (FFO) for REITs and revenue per available room (RevPAR) for hotels that provide a better basis for comparison than simple valuation metrics. However metrics like Price/Earnings, Price/Sales and Enterprise Value/EBITDA included below should provide a good starting point for analyzing the majority of stocks.

Chairman of the Board Larrea German Velasco acquired 100,000 shares of this copper mining company, paying $31.36 per share for a total amount of $3.14 million. Mr. Velasco increased his stake by 19.25% to 619,367 shares with this purchase.

Director Michael F. Hines acquired 30,000 shares of this health care products retailers, paying $35.41 per share for a total amount of $1.06 million. Mr. Hines increased his stake by 421.47% to 37,118 shares with this purchase.

This is the first insider purchase since the November 2012 cluster of insider purchases in the range of $32 to $33 per share. The stock nearly doubled following those purchase before giving back most of those gains and dropping to current levels. Top line growth appears to have stalled but the company is trading at a reasonable 8.8 times EBITDA.

Director Christian Zugel acquired 30,000 shares, paying $18.93 per share for a total amount of $567,900. Mr. Zugel increased his stake by 36.18% to 112,911 shares with this purchase.

CEO, President and Director Michael Szymanski acquired 5,300 shares, paying $18.50 per share for a total amount of $98,050. Mr. Szymanski increased his stake by 23.40% to 27,946 shares with this purchase.

Director Daniel Mudge acquired 3,000 shares, paying $18.80 per share for a total amount of $56,400. Mr. Mudge increased his stake by 100.00% to 6,000 shares with this purchase.

Director James Zinn acquired 2,650 shares, paying $18.59 per share for a total amount of $49,264. Mr. Zinn increased his stake by 82.81% to 5,850 shares with this purchase.

Director Marran H. Ogilvie acquired 1,140 shares, paying $18.71 per share for a total amount of $21,325. Ms. Ogilvie increased her stake by 36.19% to 4,290 shares with this purchase.

Vice President Coleman N. Lannum III acquired 5,820 shares, paying $87.65 per share for a total amount of $510,122. Mr. Lannum increased his stake by 88.38% to 12,405 shares with this purchase.370 of these shares were purchased indirectly by Mr. Lannum’s wife.

Vice President and Controller Richard G. Brown Jr. acquired 2,000 shares, paying $87.69 per share for a total amount of $175,388. Mr. Brown increased his stake by 3.65% to 56,764 shares with this purchase. 500 of these shares were purchased indirectly by Mr. Brown’s son.

It was a little surprising to see these purchases in light of the pending merger of Covidien with Medtronic (MDT) in a tax inversion deal that has drawn a lot of attention. The deal was the central character in Allan Sloan’s cover story in Fortune titled Positively un-American tax dodges. The spread on the deal is 8.75% (19.84% annualized if the deal closes by early next year) according to our merger arbitrage tool.

Make
a Comment

Econintersect wants your comments,
data and opinion on the articles posted. As the internet is a
"war zone" of trolls, hackers and spammers - Econintersect must balance its
defences against ease of commenting. We have joined with Livefyre
to manage our comment streams.

To comment, just click the "Sign In" button at the top-left corner of
the comment box below. You can create a commenting account using your
favorite social network such as Twitter, Facebook, Google+, LinkedIn or
Open ID - or open a Livefyre account using your email address.

No feedback yet

Econintersect Investing Blog

The growing use of ad blocking software is creating a shortfall in covering our fixed expenses. Please consider a donation to Econintersect to allow continuing output of quality and balanced financial and economic news and analysis.